Endometrial cancer in elderly women: A histologic and steroid receptor study

Gerontology

Volumn 46, Issue 1, 2000, Pages 17-21

  Deligdisch, Liane ^a,b   Kase, Nathan G ^a   Bleiweiss, Ira J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Endometrial carcinoma in elderly; Estrogen progesterone receptors

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

AGED; ARTICLE; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TISSUE SECTION; TUMOR DIFFERENTIATION;

EID: 0033989728     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022128     Document Type: Article

References (20)

1. Hofman K, Nekhliudov L, Dcligdisch L: Endometrial carcinoma in elderly women. Gynecol Oncol 1995;58:198-201.
2. Gambrell R Jr, Massey F, Castaneda T, Ugenas AJ, Ricci CA, Wright JM: Use of progestagen challenge lest to reduce the risk of endometrial cancer. Obstet Gynecol 1980;55:732-738.
3. Kurman RJ, Zaino RJ, Norris HJ: Endometrial carcinoma; in Kurman RJ (ed:) Blaustein's Pathology of the Female Genital Tract, ed 4, New York, Springer, 1994, pp 440-441.
4. Beresford SAA, Weiss NS, Voigt LF, McKnight B: Risk of endometrial cancer in relation to use of estrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 1997;349:458-461.
5. Scully RE, Poulson H, Sobin LH: International Classification and Histologic Typing of Female Genital Tract Tumors. Berlin, Springer, 1994.
6. Koshiyama M, Yoshida M, Takamura M, Yura Y, Matsushita K, Hayashi M, Tauchi K, Konishi I, Mori T: Immunohistochemical analysis of distribution of estrogen receptors and progeterone receptors in the postmenopausal endometrium. Acta Obstct Gynecol Scand 1996;75: 702-706.
7. Bergeron C, Ferenczy A, Shayamala G: Distribution of estrogen receptors in various cell types of normal, hyperplastic and neoplastic human endometrial tissues. Lab Invest 1988; 58:338-345.
8. Carcangiu M, Chambers JT, Voynick IM, Pirro M, Schwartz PE: Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Am J Clin Pathol 1990;94:247-254.
9. Deligdisch L, Holinka C: Progesterone receptors in two groups of endometrial carcinoma. Cancer 1986;57:1385-1388.
10. Deligdisch L, Holinka C: Endometrial carcinoma: Two diseases? Cancer Detect Prevent 1987;10:237-246.
11. Brustein S, Fruchter R, Greene GL, Pertchuk LP: Immunohistochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia; A preliminary evaluation. Mod Pathol 1989;2: 449-455.
12. Li SF, Shiozawa T, Nakayama K, Nikaido T, Fuji S: Stepwise abnormality of sex steroid receptors, tumor suppressor gene products (p53 and Rb) and cyclin E in uterine endometrioid carcinoma. Cancer 1996;77:321-329.
13. Koss LG: Detection of occult carcinoma. J Cell Biochem Suppl 1995;23:165-173.
14. Moll UM, Chalas E, Auguste M, Meany D: Uterine papillary serous carcinoma evolves via a p53-driven pathway. Hum Pathol 1996;12: 1295-1300.
15. Deligdisch L, Gil J, Heller D, Cohen CJ: Two types of papillary carcinoma of the endometriuni: A morphometric study. Pathol Res Pract 1992;188:473-477.
16. Umpierre SA, Burke TW, Tornos C, Ordonez N, Levenback C, Morris M: Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol 1994;13:127-130.
17. Spiegel GW: Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol 1995;19:417-431
18. Witt DM, Lonsberg TR: Progesterone essentially eliminates the risk of endometrial hyperplasia; in Controversies surrounding estrogen use in postmenopausal women. Ann Pharmacother 1997;31:745-755.
19. Langer RD, Pierce JJ, O'Hanlan KA, et al: Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. N Engl J Med 1997;337:1792-1798.
20. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS: Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 1990;45:48.